Clinical Trial Update: PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors [EARLY_Phase 1]

View source ↗

Summary

Early-phase PET imaging study evaluating 89Zr-labeled antibody fragments targeting HER2 in patients with malignant tumors to assess uptake and distribution, inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Urothelial Carcinoma

Drugs mentioned

• 89Zr-labeled HER2-targeted antibody fragment

Snippet

Sponsor: Affiliated Hospital of Jiangnan University | Conditions: Breast Cancer, Gastric Cancer (GC) | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION